I don't see any way we go longer than 18-24 months max before a buyout scenario happens. If trials go well, maybe even sooner in a 12-18 month time frame. I agree though, a steady and stable climb in SP is better than a huge spike followed by retracement. I am in the same boat, holding long until at the very least next fall, so there is no rush. I suspect many of us longs are all in the same boat (pun intended) Still just anxious to hear some results, I will feel alot better once I hear P53 is confirmed. All the dosing updates are great for shareholder transparency, but data is where the rubber really hits the road.